Cargando…

Novel 2-pheynlbenzofuran derivatives as selective butyrylcholinesterase inhibitors for Alzheimer’s disease

Alzheimer’s disease (AD) is a neurodegenerative disorder representing the leading cause of dementia and is affecting nearly 44 million people worldwide. AD is characterized by a progressive decline in acetylcholine levels in the cholinergic systems, which results in severe memory loss and cognitive...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kumar, Amit, Pintus, Francesca, Di Petrillo, Amalia, Medda, Rosaria, Caria, Paola, Matos, Maria João, Viña, Dolores, Pieroni, Enrico, Delogu, Francesco, Era, Benedetta, Delogu, Giovanna L., Fais, Antonella
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5849682/ https://www.ncbi.nlm.nih.gov/pubmed/29535344 http://dx.doi.org/10.1038/s41598-018-22747-2

Ejemplares similares

Structural Insight of New Butyrylcholinesterase Inhibitors Based on Benzylbenzofuran Scaffold
por: Delogu, Giovanna L., et al.
Publicado: (2022)

Euphorbia characias: Phytochemistry and Biological Activities
por: Fais, Antonella, et al.
Publicado: (2021)

Tyrosinase inhibition and antioxidant properties of Asphodelus microcarpus extracts
por: Di Petrillo, Amalia, et al.
Publicado: (2016)

Selected Enzyme Inhibitory Effects of Euphorbia characias Extracts
por: Fais, Antonella, et al.
Publicado: (2018)

Anti-Aging Potential of Extracts from Washingtonia filifera Seeds
por: Era, Benedetta, et al.
Publicado: (2021)

Tyrosinase Inhibitor Activity of Coumarin-Resveratrol Hybrids
por: Fais, Antonella, et al.
Publicado: (2009)

Antibacterial Activity and Molecular Docking Studies of a Selected Series of Hydroxy-3-arylcoumarins
por: Pisano, Maria Barbara, et al.
Publicado: (2019)

Washingtonia filifera seed extracts inhibit the islet amyloid polypeptide fibrils formations and α-amylase and α-glucosidase activity
por: Floris, Sonia, et al.
Publicado: (2021)

Hydroxy-3-Phenylcoumarins as Multitarget Compounds for Skin Aging Diseases: Synthesis, Molecular Docking and Tyrosinase, Elastase, Collagenase and Hyaluronidase Inhibition, and Sun Protection Factor
por: Pintus, Francesca, et al.
Publicado: (2022)

Chemical composition and enzyme inhibition of Phytolacca dioica L. seeds extracts
por: Di Petrillo, Amalia, et al.
Publicado: (2019)

Biopolymer: A Sustainable Material for Food and Medical Applications
por: Baranwal, Jaya, et al.
Publicado: (2022)

Phytochemical composition and the cholinesterase and xanthine oxidase inhibitory properties of seed extracts from the Washingtonia filifera palm fruit
por: Floris, Sonia, et al.
Publicado: (2019)

Inhibitory Effect of Quercetin on Oxidative Endogen Enzymes: A Focus on Putative Binding Modes
por: Olla, Stefania, et al.
Publicado: (2023)

Metabolomics Analysis and Modeling Suggest a Lysophosphocholines-PAF Receptor Interaction in Fibromyalgia
por: Caboni, Pierluigi, et al.
Publicado: (2014)

Hydroxylated Coumarin-Based Thiosemicarbazones as Dual Antityrosinase and Antioxidant Agents
por: Masuri, Sebastiano, et al.
Publicado: (2023)

Euphorbia characias Extract: Inhibition of Skin Aging-Related Enzymes and Nanoformulation
por: Pintus, Francesca, et al.
Publicado: (2022)

Coumarin-Resveratrol-Inspired Hybrids as Monoamine Oxidase B Inhibitors: 3-Phenylcoumarin versus trans-6-Styrylcoumarin
por: Mellado, Marco, et al.
Publicado: (2022)

Synthesis and Vasorelaxant and Platelet Antiaggregatory Activities of a New Series of 6-Halo-3-phenylcoumarins †
por: Quezada, Elías, et al.
Publicado: (2010)

Influence of Rivastigmine transdermal on butyrylcholinesterase levels in patients with Alzheimer's disease
por: dos Santos, Gustavo Alves Andrade, et al.
Publicado: (2011)

Bioseparation of Four Proteins from Euphorbia characias Latex: Amine Oxidase, Peroxidase, Nucleotide Pyrophosphatase/Phosphodiesterase, and Purple Acid Phosphatase
por: Medda, Rosaria, et al.
Publicado: (2011)

Antityrosinase activity of Euphorbia characias extracts
por: Pintus, Francesca, et al.
Publicado: (2015)

Dynamical footprint of cross-reactivity in a human autoimmune T-cell receptor
por: Kumar, Amit, et al.
Publicado: (2017)

The Butyrylcholinesterase K Variant Confers Structurally Derived Risks for Alzheimer Pathology(♦)
por: Podoly, Erez, et al.
Publicado: (2009)

Butyrylcholinesterase K Variant and Alzheimer’s Disease Risk: A Meta-Analysis
por: Wang, Zongcheng, et al.
Publicado: (2015)

Quantification of Butyrylcholinesterase Activity as a Sensitive and Specific Biomarker of Alzheimer’s Disease
por: Macdonald, Ian R., et al.
Publicado: (2017)

Butyrylcholinesterase Protein Ends in the Pathogenesis of Alzheimer’s Disease—Could BCHE Genotyping Be Helpful in Alzheimer’s Therapy?
por: Jasiecki, Jacek, et al.
Publicado: (2019)

Evolution of Acetylcholinesterase and Butyrylcholinesterase in the Vertebrates: An Atypical Butyrylcholinesterase from the Medaka Oryzias latipes
por: Pezzementi, Leo, et al.
Publicado: (2011)

Kinetics and computational study of butyrylcholinesterase inhibition by methylrosmarinate: relevance to Alzheimer’s disease treatment
por: Uzairu, Sani Muhammad, et al.
Publicado: (2022)

Correction: Evolution of Acetylcholinesterase and Butyrylcholinesterase in the Vertebrates: An Atypical Butyrylcholinesterase from the Medaka Oryzias latipes
por: Pezzementi, Leo, et al.
Publicado: (2011)

Molecular forms of butyrylcholinesterase and obesity
por: Boberg, Dellyana R., et al.
Publicado: (2010)

Caffeine Inhibits Acetylcholinesterase, But Not Butyrylcholinesterase
por: Pohanka, Miroslav, et al.
Publicado: (2013)

Electrochemical MIP Sensor for Butyrylcholinesterase
por: Ozcelikay, Goksu, et al.
Publicado: (2019)

Identification of Compounds for Butyrylcholinesterase Inhibition
por: Li, Shuaizhang, et al.
Publicado: (2021)

Broad-range potential of Asphodelus microcarpus leaves extract for drug development
por: Di Petrillo, Amalia, et al.
Publicado: (2017)

Design, Synthesis, and Evaluation of Acetylcholinesterase and Butyrylcholinesterase Dual-Target Inhibitors against Alzheimer’s Diseases
por: Guo, Yan, et al.
Publicado: (2020)

The Role of Butyrylcholinesterase and Iron in the Regulation of Cholinergic Network and Cognitive Dysfunction in Alzheimer’s Disease Pathogenesis
por: Jasiecki, Jacek, et al.
Publicado: (2021)

Aaptamine – a dual acetyl – and butyrylcholinesterase inhibitor as potential anti-Alzheimer’s disease agent
por: Miao, Shuang, et al.
Publicado: (2022)

Miguel Ángel : escultor, pintor y arquitecto
por: Delogu, G.
Publicado: (1958)

Targeting butyrylcholinesterase for preclinical single photon emission computed tomography (SPECT) imaging of Alzheimer's disease
por: DeBay, Drew R., et al.
Publicado: (2017)

Novel Selective Butyrylcholinesterase Inhibitors Incorporating Antioxidant Functionalities as Potential Bimodal Therapeutics for Alzheimer’s Disease
por: Jones, Mike, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_mu0a7daou5p94ag34h66djsdnl